Show simple item record

Risk Factors for Severe Outcomes in Patients With Systemic Vasculitis and COVID-19 : A Binational, Registry-Based Cohort Study

dc.contributor.authorRutherford, Matthew A
dc.contributor.authorScott, Jennifer
dc.contributor.authorKarabayas, Maira
dc.contributor.authorAntonelou, Marilina
dc.contributor.authorGopaluni, Seerapani
dc.contributor.authorGray, David
dc.contributor.authorBarrett, Joe
dc.contributor.authorBrix, Silke R
dc.contributor.authorDhaun, Neeraj
dc.contributor.authorMcAdoo, Stephen P
dc.contributor.authorSmith, Rona M
dc.contributor.authorGeddes, Colin C
dc.contributor.authorJayne, David
dc.contributor.authorLuqmani, Raashid
dc.contributor.authorSalama, Alan D
dc.contributor.authorLittle, Mark A
dc.contributor.authorBasu, Neil
dc.contributor.authorUK and Ireland Vasculitis Rare Disease Group (UKIVAS)
dc.date.accessioned2023-04-28T23:09:21Z
dc.date.available2023-04-28T23:09:21Z
dc.date.issued2021-09-01
dc.identifier219244248
dc.identifier4210f36c-6400-480e-8f14-58984bdc9d0c
dc.identifier33750043
dc.identifier85109773737
dc.identifier.citationRutherford , M A , Scott , J , Karabayas , M , Antonelou , M , Gopaluni , S , Gray , D , Barrett , J , Brix , S R , Dhaun , N , McAdoo , S P , Smith , R M , Geddes , C C , Jayne , D , Luqmani , R , Salama , A D , Little , M A , Basu , N & UK and Ireland Vasculitis Rare Disease Group (UKIVAS) 2021 , ' Risk Factors for Severe Outcomes in Patients With Systemic Vasculitis and COVID-19 : A Binational, Registry-Based Cohort Study ' , Arthritis & Rheumatology , vol. 73 , no. 9 , pp. 1713-1719 . https://doi.org/10.1002/art.41728en
dc.identifier.issn2326-5191
dc.identifier.otherPubMedCentral: PMC8251299
dc.identifier.otherORCID: /0000-0002-4206-477X/work/122953880
dc.identifier.urihttp://aura-test.abdn.ac.uk/handle/2164/19543
dc.format.extent7
dc.format.extent263608
dc.language.isoeng
dc.relation.ispartofArthritis & Rheumatologyen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectAgeden
dc.subjectAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/drug therapyen
dc.subjectCOVID-19/mortalityen
dc.subjectComorbidityen
dc.subjectFemaleen
dc.subjectGlucocorticoids/therapeutic useen
dc.subjectHospitalizationen
dc.subjectHumansen
dc.subjectImmunosuppressive Agents/therapeutic useen
dc.subjectIntensive Care Unitsen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectOdds Ratioen
dc.subjectOxygen Inhalation Therapy/statistics & numerical dataen
dc.subjectRegistriesen
dc.subjectRespiration, Artificial/statistics & numerical dataen
dc.subjectRespiratory Tract Diseases/epidemiologyen
dc.subjectRisk Factorsen
dc.subjectSARS-CoV-2en
dc.subjectSeverity of Illness Indexen
dc.subjectSystemic Vasculitis/drug therapyen
dc.subjectR Medicineen
dc.subjectSupplementary Informationen
dc.subject.lccRen
dc.titleRisk Factors for Severe Outcomes in Patients With Systemic Vasculitis and COVID-19 : A Binational, Registry-Based Cohort Studyen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH)en
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.description.statusPeer revieweden
dc.identifier.doihttps://doi.org/10.1002/art.41728
dc.identifier.vol73en
dc.identifier.iss9en


Files in this item

Thumbnail
Name:
Parchment_JOPH_How_Useful_Is_A ...
Size:
540.8Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record